Oligomerix in the News

October 22, 2018 – Oligomerix SFN presentation is entitled “In vivo validation of a small molecule inhibitor of tau oligomer formation in htau mice” in Session 268 – Alzheimer’s Disease and Other Dementias: Therapeutic Strategies: Preclinical Animal Models on Monday, Nov 5, 2018 at 10:15 AM in Rm. SDCC33). See link below for full abstract: https://abstractsonline.com/pp8/#!/4649/presentation/38873

October 17, 2018 – Oligomerix Awarded $1.98 Million NIH SBIR Phase IIb Grant to Advance its Lead using Transgenic Models for Alzheimer’s Disease and Frontotemporal Dementia

October 9, 2018 – Oligomerix Relocates to Albert Einstein College of Medicine Campus

October 1, 2018 – Oligomerix, Inc Awarded $2.49 Million Fast-Track National Institute on Aging SBIR Grant Funding Scale Up and Synthesis of its Lead Compound to Facilitate Initiation of IND-enabling Studies for Alzheimer’s Disease and Related Disorders

January 7-10, 2018 – Oligomerix to attend JP Morgan Healthcare Conference in San Francisco, CA to conduct partnering discussions

November 12-15, 2017 – Society for Neuroscience – Washington DC -Oligomerix to present poster entitled “In vivo efficacy study of a small molecule inhibitor of tau oligomer formation in htau mice”

July 16-20, 2017 – AAIC meeting, London U.K. – Oligomerix to present poster – “CNS Drug-like Inhibitors of Tau Oligomerization”

July 24-27, 2016 – AAIC meeting, Toronto, Canada – poster presentation

• Small Molecule Tau Oligomerization Inhibitors

May 2, 2016 – Oligomerix Awarded a Grant for its Alzheimer’s Drug Discovery Program Targeting Tau Oligomers from the National Institutes of Health

October 18-21, 2015 – SfN meeting – Chicago, IL – poster presentation

July 18-22, 2015 – AAIC meeting, Washington DC – poster presentations

• Characterization of Tool Compounds Targeting Tau Oligomers
• Identification of Tau Oligomer Proteolytic Activity as a Novel Target for Drug Discovery.

June 16-18, 2015 – BIO International Convention, Philadelphia, PA – partnering meetings

April 7-8, 2015 – Neurotech Investing & Partnering Conference, San Francisco, CA – oral presentation, partnering meetings

March 18-20, 2015 – AD/PD meeting, Nice, France – poster presentations

November 16-20, 2014 – SfN meeting, Washington DC – poster presentations

July 13-16, 2014 – AAIC meeting, Copenhagen, Denmark – poster presentations

July 5-8, 2014 – FENS meeting, Milan, Italy – poster presentation

January 13-15, 2014 – Biotech Showcase, San Francisco, CA – oral presentation

November 10-13, 2013 – SfN meeting – San Diego, CA – poster presentations

July 14-17, 2013 – AAIC meeting – Boston, MA – poster presentations